Home » Topics » BioWorld Science

BioWorld Science
RSS

Azitra raises new financing to advance pipeline

May 4, 2018

Refuge Biotechnologies completes series B financing

May 4, 2018

FDA grants orphan drug designation to BN-Brachyury as treatment for chordoma

May 4, 2018

FDA advisory committee votes to recommend Siga's Tpoxx smallpox treatment

May 3, 2018

Heptares Therapeutics divulges novel M1 and/or M4 receptor agonists

May 3, 2018

Novel mutant IDH inhibitors presented by Isocure Biosciences

May 3, 2018

TES Pharma discovers ACMSD inhibitors

May 3, 2018

Mission Therapeutics patents USP30 inhibitors

May 3, 2018

Araxes Pharma presents new mutant RAS inhibitors

May 3, 2018

FDA issues complete response letter for Sandoz rituximab biosimilar

May 3, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...